Rory Cullinan - 30 Jul 2025 Form 4 Insider Report for ACUREN CORP (TIC)

Role
Director
Signature
/s/ Fiona Sutherland, Attorney-in-Fact
Issuer symbol
TIC
Transactions as of
30 Jul 2025
Net transactions value
$0
Form type
4
Filing time
01 Aug 2025, 18:05:08 UTC
Previous filing
14 Feb 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Cullinan Rory Director C/O ACUREN CORPORATION, 14434 MEDICAL COMPLEX DRIVE, SUITE 100, TOMBALL /s/ Fiona Sutherland, Attorney-in-Fact 01 Aug 2025 0001823953

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TIC Common Stock Options Exercise $0 +10,000 +80% $0.000000 22,500 30 Jul 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TIC Restricted Stock Units Options Exercise $0 -10,000 -100% $0.000000 0 30 Jul 2025 Common Stock 10,000 Direct F3, F4
transaction TIC Restricted Stock Units Award $0 +9,017 $0.000000 9,017 31 Jul 2025 Common Stock 9,017 Direct F3, F5
holding TIC Options (Right to Buy) 50,000 30 Jul 2025 Common Stock 50,000 $11.50 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On July 30, 2025, 10,000 of the Reporting Person's restricted stock units were settled for an equal number of shares of the Issuer's Common Stock.
F2 These options are fully vested and exercisable.
F3 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
F4 These restricted stock units vest on July 30, 2025 (the one-year anniversary of the grant date).
F5 These restricted stock units vest on July 31, 2026 (the one-year anniversary of the grant date).